Skip to Main Content

Advertisement intended for health care professionals

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 1, Issue 4
January 10 2017
Issue Cover

Table of Contents

EXCEPTIONAL CASE REPORT

Hematopoietic cell transplantation for a child with OSTM1 osteopetrosis
Clinical Trials & Observations
Kathleen M. Overholt,Melissa J. Rose,Sarita Joshi,Gail E. Herman,Rajinder Bajwa,Rolla Abu-Arja,Hemalatha G. Rangarajan,Edwin M. Horwitz
View Articletitled, Hematopoietic cell transplantation for a child with OSTM1 osteopetrosis

HEMATOPOIESIS AND STEM CELLS

Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease
Randall K. Merling,Douglas B. Kuhns,Colin L. Sweeney,Xiaolin Wu,Sandra Burkett,Jessica Chu,Janet Lee,Sherry Koontz,Giovanni Di Pasquale,Sandra A. Afione,John A. Chiorini,Elizabeth M. Kang,Uimook Choi,Suk See De Ravin,Harry L. Malech
View Articletitled, Gene-edited pseudogene resurrection corrects p47<sup>phox</sup>-deficient chronic granulomatous disease
Supplemental data

LYMPHOID NEOPLASIA

Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States
Clinical Trials & Observations
Luciano J. Costa,Ilene K. Brill,James Omel,Kelly Godby,Shaji K. Kumar,Elizabeth E. Brown
View Articletitled, Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States
Supplemental data

TRANSPLANTATION

Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
Clinical Trials & Observations
Yvette L. Kasamon,Richard F. Ambinder,Ephraim J. Fuchs,Marianna Zahurak,Gary L. Rosner,Javier Bolaños-Meade,Mark J. Levis,Douglas E. Gladstone,Carol Ann Huff,Lode J. Swinnen,William H. Matsui,Ivan Borrello,Robert A. Brodsky,Richard J. Jones,Leo Luznik
View Articletitled, Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide
Supplemental data
All Issues

Advertisement intended for health care professionals

American Society of Hematology: Building a Comprehensive Minority Recruitment and Retention Professional Program
Model-based dosing for better survival after transplantation
Lezina L, Spriggs RV, Beck D, et al. CD40L/IL-4–stimulated CLL demonstrates variation in translational regulation of DNA damage response genes including ATM. Blood Adv. 2018;2(15):1869-1881.
Incremental eligibility criteria for the BMT CTN 1507 haploidentical trial for children with sickle cell disease
Adeno-associated virus–based gene therapy for hemophilia A and B: a systematic review and meta-analysis

Advertisement intended for health care professionals

Advertisement intended for health care professionals

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals